Jeffrey W Dunn (Director) sold ~$369K of Si-Bone
Planned saleSIBN · NASDAQ · Surgical & Medical Instruments & Apparatus
Surgical & Medical Instruments & Apparatus company based in Santa Clara, Ca.
In the last 90 days, no insider of Si-Bone reported an open-market purchase and 7 open-market sales worth about $520K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$19.55
Last 12 months
Not enough history
Market value
Not available
Bets against the stock: 5.91M shares sold short, +5.1% vs the previous count, 10.7 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$56M
+15.2% vs the same quarter a year earlier
Free cash flow, last 12 months
−$4.39M
This quarter −$768K, a year earlier −$1.93M
Net debt
$2.5M
Debt $35.6M, cash $33.1M, at Jun 30, 2026
Net income, last 12 months
−$14.6M
Operating profit covers interest -7.1x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 3, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
7 sales
$520K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
1 approval or clearance and 0 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.